Medline Inc. (MDLN)Healthcare | Medical Instruments & Supplies | Northfield, United States | NasdaqGS
36.57 USD
+0.64
(1.781%)
⇧
(Oct. 15, 2026, 4 p.m.
EDT)
|
Hot Take ↕ | Oct. 10, 2026, 7:59 a.m. EDT
The investment case for Medline is currently fractured by a severe disconnect between its valuation and its performance. While the company boasts impressive top-line growth of 11.6% and a forward P/E of roughly 23, the market is punishing the stock with a trailing P/E exceeding 90, reflecting a catastrophic collapse in profitability. Earnings have cratered by 82% quarter-over-quarter, and operating margins are dangerously thin at just 0.8%. This suggests the business is struggling to convert sales into profit, likely due to pricing pressure or cost inefficiencies. The price action confirms this distress; the stock is trading significantly below its 200-day average, indicating a persistent downtrend despite recent minor bounces. The options market is screaming 'sell' or 'hedge,' with traders buying deep out-of-the-money puts to protect against further declines, while call activity remains muted. There is no dividend to provide income during this transition, and the recent secondary offerings suggest existing shareholders are looking to exit rather than build long-term value. Until the earnings collapse is reversed and margins expand, the risk-reward profile remains skewed heavily toward the downside. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.073136 |
| MSTL | 0.082726 |
| AutoETS | 0.086090 |
| AutoARIMA | 0.086091 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 42% |
| H-stat | 2.44 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.128 |
| Excess Kurtosis | -0.02 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 66.258 |
| Revenue per Share | 34.138 |
| Market Cap | 49,202,491,392 |
| Trailing P/E | 91.42 |
| Forward P/E | 23.19 |
| Profit Margins | 2.31% |
| Website | https://www.medline.com |
As of Oct. 10, 2026, 7:59 a.m. EDT: Speculators are heavily positioning for downside protection with massive open interest in out-of-the-money puts (strikes 27.5, 30, 32.5) expiring in late 2026 and early 2027, indicating a fear of a significant drop. Conversely, call activity is sparse and concentrated near the money, with notable volume in strikes 40 and 45 for later 2027, suggesting limited bullish conviction compared to the defensive hedging seen in the put book.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.1080488 |
| Address1 | 3 Lakes Drive |
| All Time High | 50.876 |
| All Time Low | 31.49 |
| Ask | 39.29 |
| Ask Size | 2 |
| Audit Risk | 6 |
| Average Analyst Rating | 1.6 - Buy |
| Average Daily Volume10 Day | 7,345,940 |
| Average Daily Volume3 Month | 7,655,332 |
| Average Volume | 7,655,332 |
| Average Volume10Days | 7,345,940 |
| Bid | 33.42 |
| Bid Size | 2 |
| Board Risk | 6 |
| Book Value | 13.195 |
| City | Northfield |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 4 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 36.57 |
| Current Ratio | 4.333 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 36.865 |
| Day Low | 35.88 |
| Debt To Equity | 66.258 |
| Display Name | Medline |
| Dividend Yield | 0.0 |
| Earnings Call Timestamp End | 1,793,822,400 |
| Earnings Call Timestamp Start | 1,793,822,400 |
| Earnings Growth | 2.62 |
| Earnings Quarterly Growth | -0.82 |
| Earnings Timestamp | 1,793,795,400 |
| Earnings Timestamp End | 1,793,795,400 |
| Earnings Timestamp Start | 1,793,795,400 |
| Ebitda | 2,518,000,128 |
| Ebitda Margins | 0.0841 |
| Enterprise To Ebitda | 19.67 |
| Enterprise To Revenue | 1.654 |
| Enterprise Value | 49,529,733,120 |
| Eps Current Year | 1.54398 |
| Eps Forward | 1.57676 |
| Eps Trailing Twelve Months | 0.4 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 34.657 |
| Fifty Day Average Change | 1.9129982 |
| Fifty Day Average Change Percent | 0.05519803 |
| Fifty Two Week Change Percent | -10.80488 |
| Fifty Two Week High | 50.876 |
| Fifty Two Week High Change | -14.306 |
| Fifty Two Week High Change Percent | -0.2811935 |
| Fifty Two Week Low | 31.49 |
| Fifty Two Week Low Change | 5.08 |
| Fifty Two Week Low Change Percent | 0.16132106 |
| Fifty Two Week Range | 31.49 - 50.876 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,765,981,800,000 |
| Float Shares | 369,496,465 |
| Forward Eps | 1.57676 |
| Forward P E | 23.193129 |
| Free Cashflow | 850,625,024 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 45,000 |
| Fullday Change | 0.08000183 |
| Fullday Change Percent | 0.21876356 |
| Fullday Price | 36.65 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,790,812,800 |
| Gross Margins | 0.25094 |
| Gross Profits | 7,512,999,936 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.0025799999 |
| Held Percent Institutions | 1.12314 |
| Implied Shares Outstanding | 1,345,433,195 |
| Industry | Medical Instruments & Supplies |
| Industry Disp | Medical Instruments & Supplies |
| Industry Key | medical-instruments-supplies |
| Ipo Expected Date | 2,025-12-17 |
| Is Earnings Date Estimate | 0 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam gloves, skin care and incontinence products, environment cleaning supplies, textiles, hand sanitizer, durable medical equipment, patient plastics, and decolonization and infection control products. Its surgical solutions provide operating room and perioperative environment product solutions, including surgical procedure trays, drapes and gowns, personal protective equipment, sterile wraps, surgical instruments, surgeon's gloves, procedure kits, and orthopedic implants. Its laboratory and diagnostics offer laboratory and diagnostic product solutions, including point of care testing, analyzers and instrumentation, lab and diagnostic consumables, diagnostic instruments, vital signs monitors, and anatomic pathology and phlebotomy products. It provides its products to domestic and international consumers. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands. It provides logistics and supply chain optimization services to domestic and international consumers. It also provides supply chain optimization services, such as consulting engagements, outsourced warehouse and technology management, put-away-ready packaging, third-party logistics, inventory rationalization, and route planning. The company was founded in 1966 and is based in Northfield, Illinois. |
| Long Name | Medline Inc. |
| Market | us_market |
| Market Cap | 49,202,491,392 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_1967303892 |
| Most Recent Quarter | 1,782,518,400 |
| Net Income To Common | 701,000,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 30,093,146,777 |
| Number Of Analyst Opinions | 26 |
| Open | 35.88 |
| Operating Cashflow | 1,992,000,000 |
| Operating Margins | 0.0082 |
| Overall Risk | 4 |
| Payout Ratio | 0.0 |
| Phone | 847 949 5500 |
| Pre Market Change | 0.08000183 |
| Pre Market Change Percent | 0.21876356 |
| Pre Market Price | 36.65 |
| Pre Market Time | 1,792,151,994 |
| Previous Close | 35.93 |
| Price Eps Current Year | 23.68554 |
| Price Hint | 2 |
| Price To Book | 2.7715044 |
| Price To Sales Trailing12 Months | 1.6434247 |
| Profit Margins | 0.02315 |
| Quick Ratio | 2.45 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | buy |
| Recommendation Mean | 1.55556 |
| Region | US |
| Regular Market Change | 0.639999 |
| Regular Market Change Percent | 1.78124 |
| Regular Market Day High | 36.865 |
| Regular Market Day Low | 35.88 |
| Regular Market Day Range | 35.88 - 36.865 |
| Regular Market Open | 35.88 |
| Regular Market Previous Close | 35.93 |
| Regular Market Price | 36.57 |
| Regular Market Time | 1,792,094,401 |
| Regular Market Volume | 7,659,803 |
| Return On Assets | 0.02464 |
| Return On Equity | 0.04935 |
| Revenue Growth | 0.116 |
| Revenue Per Share | 34.138 |
| Sand P52 Week Change | 0.16207206 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 3 |
| Shares Outstanding | 877,351,218 |
| Shares Percent Shares Out | 0.060100004 |
| Shares Short | 52,686,646 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 39,481,289 |
| Short Name | Medline Inc. |
| Short Percent Of Float | 0.1251 |
| Short Ratio | 6.12 |
| Source Interval | 15 |
| State | IL |
| Symbol | MDLN |
| Target High Price | 55.0 |
| Target Low Price | 34.0 |
| Target Mean Price | 44.42308 |
| Target Median Price | 45.0 |
| Total Cash | 2,700,000,000 |
| Total Cash Per Share | 3.077 |
| Total Debt | 12,640,000,000 |
| Total Revenue | 29,938,999,296 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | 0.4 |
| Trailing P E | 91.424995 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 40.051376 |
| Two Hundred Day Average Change | -3.4813766 |
| Two Hundred Day Average Change Percent | -0.08692277 |
| Type Disp | Equity |
| Volume | 7,659,803 |
| Website | https://www.medline.com |
| Zip | 60,093 |